Perfil
Dr. Christian Weyer, MD, is a Chief Medical Officer at Prolynx, Inc (California).
Dr. Weyer was previously employed as a President & Chief Medical Officer by Escient Pharmaceuticals, Inc., an Executive Vice President-Research & Development by Intercept Pharmaceuticals, Inc., a President & Chief Development Officer by Profil Institute for Clinical Research, Inc., a President & Chief Development Officer by ProSciento, Inc., a President, Chief Executive Officer & Director by Fate Therapeutics, Inc., a Senior Vice President-Research & Development by Amylin Pharmaceuticals, Inc., and a Director-Accounting, Sales & Marketing by EKF-diagnostic GmbH.
He received his graduate degree from the University of California San Diego and a doctorate degree from Heinrich-Heine-Universität Düsseldorf.
Cargos activos de Christian Weyer
| Empresas | Cargo | Inicio |
|---|---|---|
ProLynx Inc /CA/
ProLynx Inc /CA/ BiotechnologyHealth Technology Operates as a biotechnology company that develops ultra-long-acting medicines for obesity | Corporate Officer/Principal | 01/03/2025 |
Antiguos cargos conocidos de Christian Weyer.
| Empresas | Cargo | Fin |
|---|---|---|
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug discovery and development company | Presidente | 01/06/2024 |
Profil Institute for Clinical Research, Inc.
Profil Institute for Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as scientific research institute | Presidente | 01/11/2017 |
ProSciento, Inc.
ProSciento, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a specialty clinical research organization | Presidente | 01/11/2017 |
| FATE THERAPEUTICS, INC. | Director Ejecutivo | 01/11/2015 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Director Técnico/Científico/I+D | - |
Formación de Christian Weyer.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 10 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Intercept Pharmaceuticals, Inc.
Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Heinrich-Heine-Universität Düsseldorf
Heinrich-Heine-Universität Düsseldorf Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Profil Institute for Clinical Research, Inc.
Profil Institute for Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as scientific research institute | Commercial Services |
Fate Therapeutics, Inc.
Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
EKF-diagnostic GmbH
EKF-diagnostic GmbH Medical SpecialtiesHealth Technology Develops, manufactures and distributes medical equipment | Health Technology |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug discovery and development company | Health Technology |
ProSciento, Inc.
ProSciento, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a specialty clinical research organization | Commercial Services |
ProLynx Inc /CA/
ProLynx Inc /CA/ BiotechnologyHealth Technology Operates as a biotechnology company that develops ultra-long-acting medicines for obesity | Health Technology |
- Bolsa de valores
- Insiders
- Christian Weyer
















